After a six-week trial, a jury found former pharmaceutical executive Martin Shkreli guilty of three of eight counts related to a scheme in which prosecutors said he defrauded investors into two hedge funds and paid them back by pilfering another company he formed.

The jury of seven women and five men, who deliberated for five days and handed up their verdict after 2 p.m. on Aug. 4 found Shkreli guilty on two counts of securities fraud and one count of conspiracy to commit securities fraud.